These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 830773)
21. Studies on some coagulation factors (Hageman factor, plasma prekallikrein, and high molecular weight kininogen) in the normal newborn. Gordon EM; Ratnoff OD; Saito H; Gross S; Jones PK Am J Pediatr Hematol Oncol; 1980; 2(3):213-6. PubMed ID: 7435882 [TBL] [Abstract][Full Text] [Related]
22. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions. Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394 [TBL] [Abstract][Full Text] [Related]
23. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems. Saito H; Ratnoff OD J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996 [TBL] [Abstract][Full Text] [Related]
24. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089 [TBL] [Abstract][Full Text] [Related]
26. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation. Saito H; Ratnoff OD Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254 [TBL] [Abstract][Full Text] [Related]
27. [Plasma kallikrein-kinin system in hypercoagulable state (author's transl)]. Koie K; Kamiya T; Takamatsu J; Hayashi K; Saito H Rinsho Ketsueki; 1980 Jun; 21(6):704-13. PubMed ID: 6450843 [No Abstract] [Full Text] [Related]
28. Blood kinins, their concentration in normal subjects and in patients with congenital deficiency in plasma prekallikrein and kininogen. Scicli AG; Mindroiu T; Scicli G; Carretero OA J Lab Clin Med; 1982 Jul; 100(1):81-93. PubMed ID: 6919569 [TBL] [Abstract][Full Text] [Related]
29. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator. Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248 [TBL] [Abstract][Full Text] [Related]
30. Fujiwara trait: the first case of kininogen deficiency in Japan. Oh-Ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I Adv Exp Med Biol; 1979; 120B():93-9. PubMed ID: 517263 [TBL] [Abstract][Full Text] [Related]
31. Severe Fletcher factor (plasma prekallikrein) deficiency with partial deficiency of Hageman factor (factor XII): report of a case with observation on in vivo and in vitro leukocyte chemotaxis. Poon MC; Moore MR; Castleberry RP; Lurie A; Huang ST; Lehmeyer J Am J Hematol; 1982 May; 12(3):261-70. PubMed ID: 6919394 [TBL] [Abstract][Full Text] [Related]
32. Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver disease. Cordova C; Violi F; Alessandri C; Ferro D; Saliola M; Balsano F J Clin Pathol; 1986 Sep; 39(9):1003-5. PubMed ID: 3639088 [TBL] [Abstract][Full Text] [Related]
33. The kallikrein-kinin system of sweat in normal and cystic fibrosis subjects. Zucollo A; Martiarena J; Luna C; Pivetta O; Villagra A; Catanzaro O Agents Actions Suppl; 1992; 38 ( Pt 3)():493-8. PubMed ID: 1462883 [TBL] [Abstract][Full Text] [Related]
34. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Imamura T; Dubin A; Moore W; Tanaka R; Travis J Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782 [TBL] [Abstract][Full Text] [Related]
35. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. Scott CF; Colman RW J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin. Kleniewski J; Blankenship DT; Cardin AD; Donaldson V J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355 [TBL] [Abstract][Full Text] [Related]
38. [Nature of the proteinase activated by the contact factor in human blood plasma]. Veremeenko KN; Kizim AI; Lositskaia VM Vopr Med Khim; 1977; (3):391-6. PubMed ID: 196405 [TBL] [Abstract][Full Text] [Related]
39. Assay methods for prekallikrein and kininogens and their applications. Uchida Y; Ohishi S; Tanaka K; Harada Y; Ueno A; Katori M; Funahashi S; Hashimoto T; Ueno T; Kodama J Adv Exp Med Biol; 1979; 120A():173-84. PubMed ID: 495307 [TBL] [Abstract][Full Text] [Related]
40. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa). Alving BM; Tankersley DL; Mason BL J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]